March 1 (Reuters) - Nuvo Pharmaceuticals Inc NRI.TO :
* Nuvo Pharmaceuticals announces 2016 year-end and fourth quarter results
* Q4 revenue C$5.6 million versus C$7.7 million
* Nuvo Pharmaceuticals - total revenue for three months ended Dec 31, 2016 was $5.6 million compared to $7.7 million for three months ended December 31, 2015
* Nuvo Pharmaceuticals - net income from continuing operations $1.7 million for three months ended Dec 31, 2016 compared to $4.7 million for three months ended Dec 31, 2015
* Nuvo Pharmaceuticals Inc- company expects pennsaid 2% phase 3 trial to be completed and top-line results available in Q2 2017 Source text for Eikon: ID:nPn6bWqg4a Further company coverage: NRI.TO